CHEMOTHERAPY-INDUCED NEUTROPENIA

Clinical trials for CHEMOTHERAPY-INDUCED NEUTROPENIA explained in plain language.

Never miss a new study

Get alerted when new CHEMOTHERAPY-INDUCED NEUTROPENIA trials appear

Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED NEUTROPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1 Terminated 1

Drug trial aims to shield patients from harsh chemo side effects while fighting bladder cancer

Disease control Terminated

This study tested if adding a drug called trilaciclib to standard first-line chemotherapy and immunotherapy could better control advanced bladder cancer. The goal was to see if trilaciclib could help patients live longer without their cancer worsening while also protecting their …

Matched conditions: CHEMOTHERAPY-INDUCED NEUTROPENIA

Phase: PHASE2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

CHEMOTHERAPY-INDUCED NEUTROPENIA

Get alerted when new CHEMOTHERAPY-INDUCED NEUTROPENIA trials appear

Drug trial aims to shield patients from harsh chemo side effects while fighting bladder cancer